JP EN

TBAP

Triple Bridge Acceleration Program

LEARN MORE

TBAP

Triple Bridge Acceleration Program

LEARN MORE
Triple Bridge Acceleration Program “TBAP” aims to support the commercialization of academic research in the medical and life science fields.

Overview

A collaborative program where each participant is tasked with achieving commercialization

Support

The Acceleration Program aims to support the commercialization of academic research in the medical and life science fields.

Awareness Building and Education

Preparing for Commercialization

Project Review

Funding and Resource Support

Collaboration

In TBAP, research institutions, strategic companies, and institutional investors collaborate to commercialize academic research.

Academia

(Universities, research institutions, hospitals, etc.)

  • Improve competitiveness as a research institution and support research efforts of its researchers.
  • Cost sharing of resources and infrastructure required for commercialization.

Businesses

(Pharmaceutical and food companies, medical device manufacturers, etc.)

  • Access to commercialization seeds and cost sharing of sourcing.
  • Diversification of eary stage risk.

Financial Investors

(VC, institutional investors)

  • Access to investment opportunities.
  • Enhanced due diligence in health care related investments.

Team

Experts from academia, business, and finance will collaborate in TBAP to commercialize research.

Membership

Academia

Kyushu University

Corporate

Support / Affiliates

Management Company

AIFAM

  • Established in 2001 as an Investment Manager for alternative investments (hedge funds, private equity, venture capital funds) Manages over $700mn with 22 professionals, located in New York and Tokyo.
  • Lead investment manager for alternative investments of top-tier Japanese institutional investors providing custom tailored solutions.
Learn more about AIFAM